Picture of Jeisys Medical logo

287410 Jeisys Medical Share Price

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Momentum

Relative Strength (%)
1m-11.88%
3m-33.74%
6m-39.49%
1yr-9.37%
Volume Change (%)
10d/3m-18.69%
Price vs... (%)
52w High-42.62%
50d MA-13.49%
200d MA-22.73%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)14.65
PEG Ratio (f)0.52
EPS Growth (f)38.76%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value6.9
Price to Tang. Book7.03
Price to Free Cashflow21.13
Price to Sales4.63
EV to EBITDA14.83

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital35.34%
Return on Equity33.26%
Operating Margin26.85%

Financial Summary

Year End 31st DecUnit201820192020202120222023E2024ECAGR / Avg
Total RevenueKR₩mn/an/an/a81,296116,549.56146,197180,200n/a
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/an/an/an/a+105.91+10.35+38.76n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Jeisys Medical EPS forecast chart

Profile Summary

Jeisys Medical Inc, formerly Yuanta 3 Special Purpose Acquisition Co Ltd, a Korea-based company principally engaged in the manufacturing and distribution of medical devices. The Company manufactures and sells skin care medical devices such as ULTRAcel Q+, POTENZA, and other products. In addition, the Company also provides consumables such as cartridges and tips.

Directors

    Last Annual
    December 31st, 2022
    Last Interim
    September 30th, 2023
    Incorporated
    December 1st, 2017
    Public Since
    May 8th, 2018
    No. of Shareholders
    26,855
    Sector
    Healthcare Equipment & Supplies
    Industry
    Healthcare
    Exchange
    kr flag iconKorea Exchange - KOSDAQ
    Shares in Issue
    75,262,519

    287410 Share Price Performance

    Upcoming Events for 287410

    Similar to 287410

    Picture of Access Bio logo

    Access Bio

    kr flag iconKorea Exchange - KOSDAQ

    Picture of Aligned Genetics logo

    Aligned Genetics

    kr flag iconKorea Exchange - KOSDAQ

    Picture of Asta Co logo

    Asta Co

    kr flag iconKorea Exchange - KOSDAQ

    Picture of Biodyne Co logo

    Biodyne Co

    kr flag iconKorea Exchange - KOSDAQ

    Picture of Bistos Co logo

    Bistos Co

    kr flag iconKorea Exchange - KOSDAQ

    FAQ